The truncated somatostatin receptor sst5TMD4 is overexpressed in prostate cancer, where it increases aggressiveness features by regulating key tumor suppressors and oncogenes.Daniel Hormaechea‐Agulla, Raúl M. Luque, Jimenez-Vacas Juan Manuel et al.|Endocrine Abstracts|2016Cited by 0
Engrailed-2 as a novel biomarker for prostate cancerGómez E. Gómez, Raúl M. Luque, Rosa J. Valero et al.|European Urology Supplements|2016Cited by 0